Komen Greater CETX and Milburn Foundation partner to combat inflammatory breast cancer
For the more than 3.8 million people diagnosed with breast cancer in the U.S., there is nothing more precious than time to fulfill dreams and share special moments with loved ones.
In just the two minutes it takes to read this post, another woman in the U.S. will be diagnosed with breast cancer. This includes inflammatory breast cancer (IBC), an aggressive breast cancer that is especially difficult to diagnose.
To change the future for women diagnosed with IBC, Susan G. Komen® Greater Central & East Texas has partnered with one of our strongest advocates for research to cure breast cancer, the Milburn Foundation®, which has generously offered to match* gifts made by March 31, 2020, to reach a collective goal of raising $100,000 – the largest goal Komen Greater CETX has ever set to support IBC research.
IBC is notoriously tough to diagnose because the symptoms – such as swelling and redness – are unlike those of other breast cancers, and often these more visible signs won’t appear until the cancer is well advanced. Standard screening is not always effective with IBC because it spreads so quickly and can be difficult to detect on a mammogram.